personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the September issue of The Medicine Maker! This issue marks the magazine’s third anniversary since our release. Our cover features unites six industry gurus to discuss the impending US and EU deadlines for serialization compliance in the pharma industry. Upfront covers the landmark approval of Kymriah, how gold nanoparticles can bypass chemotherapy toxicity, and why drugs fail in clinical trials, or even post-approval. In NextGen, experts cover the challenges of manufacturing cell therapies, and why ex vivo screening could boost new drug development. Plus, we sit down with Abhijit Mukherjee from Dr Reddys to talk about the business of generics.